Clinical Trial Update: Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS) [Phase 2]

View source ↗

Summary

Phase 2 trial of Chiauranib for advanced or unresectable soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Chiauranib (Chiauranib)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED